Monitoring systemic lupus erythematosus in standard clinical care.
Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease with a fluctuating and unpredictable course. Monitoring SLE in the routine clinic setting is a challenge because both the disease and its treatment can result in organ damage. Disease activity indices and a cumulative history summary can be used to track complicated patients over time. Monitoring guidelines for damage from the disease and for the toxicity of treatment are available.
Johns Hopkins University School of Medicine, 1830 E Monument St Suite 7500, Baltimore, MD 21205, USA. mpetri@jhmi.edu
Michelle
M
Petri
D003625:Data Collection; D019468:Disease Management; D005938:Glucocorticoids / Q000009:adverse effects; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000150:complications / Q000188:drug therapy / Q000628:therapy*; D008499:Medical Records; D010808:Physical Examination; D011241:Prednisone / Q000009:adverse effects; D011788:Quality of Life
D005938:Glucocorticoids; D011241:Prednisone